Thought Leaders in
Precision Medicine
The COVID-19 pandemic revealed that molecular diagnostic PCR Technology is the emerging gold standard for swab testing patients’ specimens for pathogen detection and diagnosis. Our CLIA-certified laboratory has been a pioneer in the testing field since its inception in 2017, long before the devastating pandemic was announced. NCF Diagnostics & DNA Technologies invests in training and education to develop laboratory infrastructure and maintain a highly skilled team of experts. Innovating new molecular diagnostic PCR pathogen assays daily, NCF Diagnostics & DNA Technologies endeavors to continue leading PCR Testing with our exceptional workforce, always keeping the “patient first” philosophy of care.
Thought Leaders in Precision Medicine
The COVID-19 pandemic revealed that molecular diagnostic PCR Technology is the emerging gold standard for swab testing patients’ specimens for pathogen detection and diagnosis. Our CLIA–certified laboratory has been a pioneer in the testing field since its inception in 2017, long before the devastating pandemic was announced. NCF Diagnostics & DNA Technologies invests in training and education to develop laboratory infrastructure and maintain a highly skilled team of experts. Innovating new molecular diagnostic PCR pathogen assays daily, NCF Diagnostics & DNA Technologies endeavors to continue leading PCR Testing with our exceptional workforce, always keeping the “patient first” philosophy of care.
Empowering Providers Through Molecular Diagnostic Technologies
Empowering Providers Through Molecular Technologies
Every Year in the United States….
20 million
COVID-19 patients tested in 2020.
38 million
Respiratory Illnesses in 2019-2020.
105 million
Gastroinestinal Disorders yearly.
2 million
Serious adverse reactions linked to antibiotics annually.
COVID-19 Death Toll: 530,000
and rising daily. The COVID-19 pandemic rages on, devastating patients, families and populations worldwide.
22,000
Deaths annually due to Flu viruses alone.
C. DIFF
Hospitalizes 250,000 patients annually, and 236,000 deaths result each year from Norovirus, C. diff and other common pathogens.
23,000
Deaths annually from antibiotic resistant infections.
Every Year in the United States….
20 million
COVID-19 patients tested in 2020.
COVID-19 Death Toll: 530,000
and rising daily. The COVID-19 pandemic rages on, devastating patients, families and populations worldwide.
38 million
Respiratory Illnesses in 2019-2020.
22,000
Deaths annually due to Flu viruses alone.
105 million
Gastroinestinal Disorders yearly.
C. DIFF
Hospitalizes 250,000 patients annually, and 236,000 deaths result each year from Norovirus, C. diff and other common pathogens.
2 million
Serious adverse reactions linked to antibiotics annually.
23,000
Deaths annually from antibiotic resistant infections.
